Answers are grounded in this paper and cite their sources.
The vitamin E activity of a-tocopherylquinone and its corresponding hydroquinone has remained a subject of interest, The quinone has been shown to be present in animal tissues (Morton & Phillips, 1959; Diplock, Green, Edwin & Bunyan, 1960)~ and Csallany, Draper & Shah (1962) have identified it as a metabolite of a-tocopherol in rat liver. Either substance, or both, may play a part in the biological function of vitamin E ; a scheme typical of several suggested is that of Slater (1961). Golumbic & Mattill (1940) found the quinone inactive in preventing foetal resorption in the rat when given orally, and Issidorides & Mattill (1951) found a single 25 mg dose of the hydroquinone, given intravenously, also ineffective. However, both substances prevent creatinuria and loss of weight in the muscular dystrophy of vitamin E-deficient rabbits (Mackenzie & McCollum, 1940 ; Mackenzie, 1942 ; Mackenzie, Rosenkrantz, Ulick & Milhorat, 1950) : the activity of the hydroquinone was much enhanced when it was given intravenously. More recently, Mackenzie & Mackenzie (1960) found that tocopherylhydroquinone, given in daily doses of 5 mg (either intraperitoneally or intravenously) during pregnancy, prevented resorption in the rat. Green, Diplock, Bunyan, Edwin & McHale (1961) reported that tocopherylquinone, given in daily 10 mg doses from the 7th to the 13th day of pregnancy, was also effective.
No takes yet. Share an insight, caveat, or question.
Bunyan et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: